Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Michael Kaplan

Sports Medicine Middlebury, CT Medical Doctor

NPI 1124047196 CMS profile 231638

1579 Straits Turnpike, Middlebury, CT 06762

Open in the dashboard

General payments

$385,195

81 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Michael Kaplan of Middlebury, CT is reported in the CMS Open Payments database as having received $385,195 across 81 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $48 1
2023 General $24,047 6
2022 General $108,802 22
2021 General $81,694 15
2020 General $83,984 13
2019 General $86,619 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Kaplan
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Michael Kaplan were reported at $0. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Michael Kaplan Sports Medicine median Middle half National median
2019 $86,619 $1,176 $199–$4,249 $163
2020 $83,984 $708 $96–$2,890 $114
2021 $81,694 $1,213 $152–$3,994 $132
2022 $108,802 $1,230 $159–$3,998 $149
2023 $24,047 $584 $146–$2,836 $160
2024 $48 $628 $163–$3,168 $164
2025 $0 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Encore Medical, LP $372,281 21 payments
  2. EMD Serono, Inc. $8,345 11 payments
  3. Celularity, Inc. $1,855 2 payments
  4. Smith+Nephew, Inc. $1,768 24 payments
  5. KCI USA, Inc $493 2 payments
  6. Horizon Therapeutics plc $137 9 payments
  7. OSSIO Inc. $88 1 payment
  8. DePuy Synthes Sales Inc. $62 3 payments
  9. Bioventus LLC $43 2 payments
  10. Ferring Pharmaceuticals Inc. $42 2 payments
  11. Other $81 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Royalty or License $371,279 17 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,900 1 payment
  3. Travel and Lodging $2,869 10 payments
  4. Consulting Fee $2,200 2 payments
  5. Food and Beverage $1,947 51 payments
Products named General payments · program years 2019–2024
  1. DJO Surgical Empowr Knee System Joint Implants $166,577 8 payments
  2. DJO SURGICAL Joint Implants $124,052 7 payments
  3. DJO Surgical Empowr Knee System Joint Implants $81,387 4 payments
  4. Navio Surgical System $440 6 payments
  5. Legion Revision $321 3 payments
  6. Journey II BCS $321 3 payments
  7. DJO SURGICAL Joint Implants $265 2 payments
  8. NAVIO $141 3 payments
  9. Acticoat Range $138 2 payments
  10. DUEXIS $137 9 payments
  11. Other $1,045 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

181

Median for Sports Medicine: 144

Drug cost

$1,821

Median for Sports Medicine: $1,027

Branded share of claims

34.3%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 17 $1,075
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 36 $274
Oxycodone Hcl Generic 17 $160
Ondansetron Odt Ondansetron Brand 26 $124
Amoxicillin Generic 60 $102
Tramadol Hcl Generic 11 $46
Meloxicam Generic 14 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$117,578

Of which drugs: $18,307

Medicare patients

349

Average age 76

Services billed

6,778

202 women, 147 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 27%
Ischemic heart disease 26%
Atrial fibrillation 20%
Chronic kidney disease 17%
Cancer 17%
Osteoporosis 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 26 2,101 $10,703
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 159 1,984 $1,488
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 164 1,036 $89

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record